Trial Profile
A trial to study cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Orthostatic hypotension
- Focus Adverse reactions
- 28 Apr 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology